https://www.foxbusiness.com/video/6355462239112
Hims and Hers stock gains momentum over obesity drugs | Fox Business Video
'Barron's Roundtable' discusses the obesity drug demand, investing in Nike and Delta Airlines' performance.
hims and hers
https://www.scrippsnews.com/health/medicine/hims-and-hers-likely-to-stop-selling-cheaper-versions-of-glp-1-medications
Hims and Hers likely to stop selling cheaper versions of GLP-1 medications
Feb 25, 2025 - The FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded versions due to regulatory changes.
hims and hers
https://www.denver7.com/health/medicine/hims-and-hers-likely-to-stop-selling-cheaper-versions-of-glp-1-medications
Hims and Hers likely to stop selling cheaper versions of GLP-1 medications
Feb 25, 2025 - The FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded versions due to regulatory changes.
hims and hers
https://www.fox17online.com/health/medicine/hims-and-hers-likely-to-stop-selling-cheaper-versions-of-glp-1-medications
Hims and Hers likely to stop selling cheaper versions of GLP-1 medications
Feb 25, 2025 - The FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded versions due to regulatory changes.
hims and hers
https://www.tampabay28.com/health/medicine/hims-and-hers-likely-to-stop-selling-cheaper-versions-of-glp-1-medications
Hims and Hers likely to stop selling cheaper versions of GLP-1 medications
Feb 25, 2025 - The FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded versions due to regulatory changes.
hims and hers